Navigation
Content
footer
HOME
SITEMAP
KOREAN
Quick Search
quick search
main navigation
About Us
Overview
History of YJP
Mission & Vision
CEO Message
Organization
Products
Finished Products
API
Search
R&D
R&D overview
Pipeline
Investor Relation
Financial Statements
Press Room
Contact Us
Contact Us
Location
KT&G
HOME
Press Room
Financial Statements
Press Room
search option
All
Subject
Content
Search
list search
press release List
No
Subjects
Date
hit
40
Yungjin signed a collaborative research agreement with Curome for treatment of rare mitochondrial disease
2021-09-13
1496
39
Abliva announces positive clinical phase 1a/b results in PMD patients for KL1333 that has been in-licensed from Yungjin
2021-05-31
1000
38
Family-Friendly certification proves that Yungjin Pharm is a great place to work
2020-12-02
872
37
Yungjin PharmĄ¯s Jeonju Factory, Practicing the love of neighbors through rice donation
2020-11-27
1072
36
Yungjin Pharm Signs $11M Contract Extension to Supply Cephalosporin-based Antibiotics with Mylan Seiyaku.
2020-10-21
964
35
Yungjin Pharm signs Collaborative Research Agreement for Parkinson's Disease Treatment
2020-10-20
827
34
Yungjin Pharm and Guangzhou Tosun(China) Contracted a Supply Agreement of Cefcapene Pivoxil
2020-07-29
934
33
Yungjin Pharm donated 'Alvityl Plus D Syrup' to Holt children's services, Inc.
2020-07-22
701
32
At AACR 2020, YJP presents significant data regarding antitumor activity
2020-07-01
715
31
Yungjin Pharm's Investor Relations(IR) Conference in 2019
2019-12-29
925
1
2
3
4